Figures 2 and 3 show that the expression of Aβ and p-Tau was significantly lower in the AD + BM25-H (Aβ: 1937.75 ± 264.35; p-Tau: 394.87 ± 36.26) and AD + BM25-M groups (Aβ: 2040.46 ± 116.74; p-Tau: 529.98 ± 78.53) than in the AD + NS group. The gene discussed is MAPT; the disease is Alzheimer disease.